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ABSTRACT
E.N. QUIROGA, A.R. SAMPIETRO AND M.A. VATTUONE. 2004.
Aims: To evaluate the fungitoxic activity of Larrea divaricata Cav. extract and one of its components against yeasts
and fungi. This activity was compared with the action of ketoconazole, a known synthetic antimycotic.
Methods and Results: Antifungal activity of Larrea divaricata extract and of a fraction (Fr. B) purified by thin
layer chromatography, was investigated using different methodologies. Both exhibited strong activity against the
majority of the assayed fungi. Only Fusarium oxysporum and Schizophyllum commune growth was not affected with
the assayed conditions. The fungitoxic and cytotoxic activity of the ethanolic extract and ketoconazole were
compared.
Conclusions: Ethanolic extracts of L. divaricata Cav. produce growth inhibition of several fungi. One of its
constituents with the same activity was purified and identified as a glycoside of a flavanone. A comparison with the
action of ketoconazole, which is currently used as antimycotic and can cause adverse health effects was made.
Significance and Impact of the Study: Our data suggest that L. divaricata extract contains, at least, one
compound of phenolic nature, with fungitoxic potency against yeasts and fungi.
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INTRODUCTION
As plants are sessile, they synthesize a vast array of
secondary metabolites as defence mechanisms for protecting
themselves against pathogen infections (bacteria, fungi and
viruses) (Osbourn 1996; Mendoza et al. 1997; Skadhange
et al. 1997; Tereschuk et al. 1997; Bois et al. 1999; Hou and
Forman 2000; Rauha et al. 2000). Although there are several
natural and synthetic products available to ameliorate fungal
infections, it is recognized that infections induced by fungi
are in a continuous increase (Wu 1994; Walsh et al. 1996).
Consequently, there are needs to detect new sources of
antifungal compounds with potential application in medicine
and also as additives in food and feed preservatives.
Previously, we reported a systematic biological investi-
gation of the in vitro antimicrobial activity of ethanolic
extracts of some Argentine plants used in traditional
medicine (Quiroga et al. 2001). The exploration of new
antifungal compounds has lead to a joint interest of
agriculture, chemistry and medicine in fundamental
research. Furthermore, the identification of naturally
occurring fungicidal compounds without toxicity for cells
would be beneficial.
The purpose of this work was to demonstrate the presence
of antifungal compounds in Larrea divaricata Cav. extracts
and the partial purification of bioactive compounds. We also




Aerial parts of L. divaricata Cav. (family Zygophylaceae)
were collected in Amaicha del Valle, Tucumán, Argentina.
This plant is popularly known as ‘jarilla’ or ‘jarilla hembra’.
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Plants were identified and taxonomically characterized by
Dr A.R. Sampietro (Instituto de Estudios Vegetales, Fac-
ultad de Bioquı́mica, Quı́mica y Farmacia, Universidad
Nacional de Tucumán, Argentina). Voucher specimens were
preserved in this chair and in the Instituto ‘Miguel Lillo’
(Tucumán, Argentina). Plant material was dried in the shade
in a well-ventilated chamber, ground to a coarse powder and
stored in the dark at room temperature.
Chemicals
All chemicals and reagents used were of the highest grade
commercially available. Ketoconazole (Parafarm, Droguerı́a
Saporiti, Argentina) was used as an antifungal drug. Stock
ethanolic solution were prepared (0Æ1–10 mg ml)1) and
stored at )18C until it was used.
Micro-organisms
The micro-organisms used included four xylophagous fungi:
Pycnoporus sanguineus (E. ex Fr.) Murr. (IEV 006), Lenzites
elegans Spreng. Ex Fr. (IEV 012), Schizophyllum commune
Fr. (IEV 009) and Ganoderma applanatum (Pers. Ex Walls)
Pat (IEV 017). These fungi were isolated from decaying
wood and classified in the Cátedra de Fitoquı́mica above
mentioned. The yeasts Rhodotorula sp. (IEV 001) and
Saccharomyces carlsbergensis (IEV 002) were a kind gift from
the Laboratorio de Micologı́a of the Instituto de Microbi-
ologı́a (UNT, Argentina), and the phytopathogenic fungi
Fusarium oxysporum Schlect, Penicillium notatum Westling
Trichoderma spp. and Aspergillus niger Thom and Church
were obtained from the Instituto Nacional de Tecnologı́a
Agraria (Tucumán, Argentina). All the strains were main-
tained in solid culture medium (SM: 15 g l)1 malt extract,
5 g l)1 peptone and 15 g l)1 agar). Other media used were
soft medium (SSM: 15 g l)1 malt extract, 5 g l)1 peptone
and 6 g l)1 agar) and liquid medium (LM: 15 g l)1 malt
extract, 5 g l)1 peptone).
Assays of antifungal activity
Several techniques were applied according with the nature
of the assayed fungus:
Bioautographic analysis was made on Silica gel 60 plates
(Merck, Darmstadt, Germany) by dot blot or after thin layer
chromatography (TLC) of the plant extract in different
solvents (Homans and Fuchs 1970). After plates (6 · 8 cm)
were dried under sterile conditions, they were covered with
3 ml of SSM containing 0Æ3 ml of a spore suspension of
A. niger, P. notatum or Trichoderma spp. (1 · 104 spores per
millilitre). Fungitoxic activity was macroscopically visual-
ized after incubation at 30C in a moist chamber for
48–72 h.
Hyphal radial growth assay: different concentrations of
L. divaricata extracts, ranging from 0 to 3Æ6 lg of phenolic
compounds per millilitre of the culture medium were
evaluated. A 3 mm diameter plug of an actively growing
mycelium of filamentous fungi harvested from an 8–10 days
of culture or 10 ll of spore suspensions (2Æ5 · 104 spor-
es ml)1) were placed onto the centre of Petri dishes
(60 · 15 mm) containing 5 ml of SM plus increasing extract
concentrations. Plates were incubated at 30C for 4–5 days
in a moist chamber and the percentage of growth inhibition
was calculated as (Reyes Chilpa et al. 1997):
% inhibition
¼Mycelial growth in controlmycelial growth in extracts plant
Mycelial growth in control
100:
Well-plate diffusion method: aliquots (50 ll) of a spore
suspension (1 · 104 spore ml)1) of A. niger or Trichoderma
spp. were overlaid on Petri dishes (90 mm in diameter)
containing 15 ml of SM. Six equidistant wells were made in
the medium using a sterile cork borer (4 mm in diameter). A
10 ll volume of various extract concentrations (0–24 lg of
phenolic compounds) or ethanolic ketoconazole solution
(0–10 lg) were placed in the wells. Ethanol was added as
control. The diameter of the inhibition zones were measured
after incubation at 30C for 48 h. The effect was calculated
as a mean of six tests.
Paper disc diffusion assay: paper discs (4 mm diameter;
Whatman no. 4) containing different quantities of plant
extract were placed on SM (15 ml per plate) containing
1 · 106 yeast cells per millilitre. Dishes with 96% ethanol
were used as control. Plates were incubated at 30C for 48 h
and the diameter of the inhibition zones were measured in
four different directions and the mean value and the S.D.
were calculated for each concentration.
Broth dilution assays were performed in a total volume of
0Æ2 ml in sterile polystyrene 96-well plates containing LM
and fixed concentrations of L. divaricata extract (2Æ7 lg
phenolic compounds 0Æ2 ml)1). Wells were inoculated with
10 ll of a spore suspension (1 · 104 spore per millilitre).
Controls were run simultaneously. Each experiment was
made eight times. Growth was quantified by A550 nm using
an automatic microplate reader Model 550 (Bio-Rad
Laboratories, Richmond, CA, USA) (Piecková and Roeij-
mans 1999) after incubation for 72 h at 37C and percentage
of growth inhibition was calculated.
Cell cytotoxicity assay
In vivo lethality assay of Artemia salina Leach was used
(Meyer et al. 1982). Brine shrimp eggs were placed in sea
water (3Æ8% w/v sea salt in distilled water) and incubated at
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22–24C in front of a lamp. Eggs hatch and mature within
48 h providing large number of larvae (nauplii). A conveni-
ent number of nauplii were placed in vials containing 5 ml
of sea water plus increasing concentrations of plant extract
or ketoconazole (1–1000 ppm) for comparison purpose
(Espinel-Ingroff et al. 2001). Controls were made with 96%
ethanol. Alive nauplii were counted after 16 h at 22C and
the lethal dose 50 (DL50) was calculated. Six replicates were
made.
Data and statistical analysis
Data were expressed as mean ± S.D. Lethality assays were
evaluated with Finney computer program to determine the
DL50 values and 95% confidence intervals. A copy of this
program for IBM PC’s is available with Dr J.L. McLaughlin
(Department of Medicinal Chemistry and Pharmacognosy,
School of Pharmacy, Purdue University, West Lafayette,
IN, USA).
Extract preparation
Extracts were prepared according to the Farmacopea
Nacional Argentina 6ta. Ed.. Briefly: powdered aerial parts
(10 g) were extracted with 100 ml of 96% ethanol by
maceration with stirring (40 cycles min)1) at 37C for 48 h
and filtered through Whatman no. 4 paper. The solvent of
the filtrate was removed by evaporation to dryness under
reduced pressure at 30C. The residue was dissolved in 96%
ethanol (28Æ1 mg ml)1) and used as stock solution. This
solution contained 12Æ92 mg of phenolic compounds per
millilitre.
Phytochemical screening
Silica Gel 60 F254 plates, 20 · 20 cm, Merck (Camm et al.
1975) with the solvent system toluene-ethyl acetate-formic
acid; 4 : 5 : 1, v/v, was used for the separation of the
components of the ethanolic extracts by ascendent TLC.
They were visualized by observation under u.v. light (254
and 366 nm) and qualitatively determined by staining with
the following reagents: modified Dragendorff’s reagent for
alkaloids, Folin Ciocalteau reagent for total phenolics,
methanolic potassium hydroxide for coumarins, aluminium
chloride for flavonoids and anisaldehide/sulphuric acid for
steroids and terpenes (Wagner et al. 1984).
Analytical methods
Total phenolic content was quantitatively determined by the
method of Folin Ciocalteau (Lowry et al. 1951) and
expressed as micrograms of coumarin and neutral sugars
by the phenol–sulphuric acid method (Dubois et al. 1956).
Fr. B was subjected to acid hydrolysis, briefly: 0Æ2 ml of Fr.
B were added to 0Æ2 ml of 2 N H2SO4 and heated at 100C
for 1 h. The preparation was neutralized with solid CaCO3
and centrifuged at 830 g for 5 min. The supernatant was
analysed by descendent paper chromatography on Whatman
no. 4 paper with the solvent system butanol–pyridine–water
(6 : 4 : 3, v/v). Sugars were detected by the method of
Trevelyan et al. (1950).
RESULTS
The ethanolic extracts of aerial parts of L. divaricata inhibit
the growth of several xylophagous and phytopathogenic
fungi and yeasts. Bioautographic assays on TLC showed
inhibition of spore germination of A. niger, Thichoderma spp,
and P. notatum (not shown). The hyphal radial growth
inhibition effectiveness varied from 41Æ3 to 77Æ6% for the
tested filamentous fungi when the phenolic compound
concentration was 368 lg ml)1 in the culture medium
(Table 1). Yeast growth, analysed by paper disc assay
showed that Rhodotorula spp. and S. carlsbergensis growth
was inhibited by 11Æ5 and 15Æ2 lg of phenolic compounds,
respectively, in our assay conditions. The cytotoxicity of the
plant extract was compared with ketoconazole, a well-known
synthetic fungitoxic imidazole derivative, by means of the
brine shrimp lethality bioassay. The LD50 obtained for the
L. divaricata extract and ketoconazole was 851 and 73 ppm,
respectively (Fig. 1). The fungitoxic effect of the plant
extract and ketoconazole on fungus growth was analysed by
monitoring the development of inhibition zones in the
culture media inoculated with spores of A. niger or
Trichoderma spp. As shown in Fig. 2 the antifungal potency
of ketoconazole was around 7Æ36–7Æ80 and 7Æ33–7Æ58 times
Table 1 Hyphal radial growth inhibition of filamentous fungi by the
ethanolic extract of Larrea divaricata. The L. divaricata ethanolic
extract concentration was 368 lg of phenolic compounds per millilitre
of culture medium (lg) of coumarin (0Æ8 mg of dry extract per
millilitre)
Fungi Growth inhibition (%) Antifungal activity**
L. elegans 77Æ6 ± 0Æ09 ++
S. commune 57Æ9 ± 0Æ05 ++
P. sanguineus 40Æ4 ± 0Æ03 ++
G. applanatum 41Æ3 ± 0Æ05 ++
F. oxysporum 56Æ2 ± 0Æ07 ++
P. notatum 89Æ0 ± 0Æ05 +++
A. niger 42Æ8 ± 0Æ03 ++
Trichoderma spp. 48Æ7 ± 0Æ07 ++
n ¼ 12.
*The percentage of inhibition was calculated according to Reyes Chilpa
et al. (1997).
**The antifungal activity was expressed as: (+) 20 to 40; (++) 40 to
80 and (+++) >80% growth inhibition.
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higher than the plant extract for A. niger or Trichoderma
spp., respectively.
Components of the ethanolic extract from L. divaricata
were analysed by ascendent TLC in analytical scale. Three
main fractions (Fr. A, Fr. B and Fr. C) were revealed with
reagents for phenolic compounds. Otherwise, the presence
of detectable quantities of alkaloids, coumarins, steroids and
terpenes was discarded by spraying the developed TLC with
different reagents. The separated fractions were scraped out
from the plate, eluted and adjusted to 90 lg phenolic
compounds per millilitre with methanol. Only Fr. B
prevented fungal growth at concentrations of phenolic
compounds that were half than that determined for the
crude extract. Pycnoporus sanguineus, L. elegans and
G. applanatum were assayed by hyphal radial growth test
showing that Fr. B (3Æ6 lg of phenolic compounds per
millilitre of culture medium) produced a growth inhibition
of 21, 30 and 54%, respectively (Fig. 2a,b and Table 2).
Otherwise, P. notatum, A. niger, Trichoderma spp., Rhodo-
torula spp., F. oxysporum and S. commune were tested by
broth microdilution method. In this case Fr. B (2Æ7 lg of
phenolic compounds in 0Æ2 ml) produced 49, 42, 21 and
20% of growth inhibition, respectively, but had not effect on
F. oxysporum or S. commune growth (Table 2). Fr. B showed
a bluish fluorescence under u.v. light (366 nm) and its u.v.
spectrum (200–450 nm) exhibited a maximum at around
282 nm. Furthermore, in u.v. light (366 nm) an orange
fluorescence was observed following NP/PEG treatment
that is an indicator of two adjacent hydroxyl groups in ring
B and the pale orange colour under u.v. 366 nm after
treatment with ammonium vapours a hydroxyl free group in
4¢ position. Otherwise, acid hydrolysis of Fr. B with
subsequent paper chromatography allowed separating glu-
cose and two pentoses. Moreover, a strong positive reaction
was observed after TLC treatment with FeCl3.
DISCUSSION
Previously we reported the in vitro antifungal activity of
ethanolic extracts of 10 higher plants used in folk medicine
























Fig. 1 Cytotoxicity of the ethanolic extract of Larrea divaricata and of
ketoconazole determined by means of the brine shrimp lethality
bioassay. Larrea divaricata (-d-) and of ketoconazole (-s-). The LD50





























































Micrograms of phenolic compounds or
ketoconazole
Micrograms of phenolic compounds or
ketoconazole
Fig. 2 Antifungal potency of the ethanolic extract of Larrea divaricata
(-s-) and of ketoconazole (-d-) on Aspergillus niger (a) and Trichoderma
spp. (b) growth. Arrows indicate the amount of phenolic compounds
and of ketoconazole necessary to attain an inhibition zone of 20 mm in
diameter, respectively. The tendence line is indicated (n ¼ 6)
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selected for this study because it showed the broadest
spectrum of activity. The fungal growth inhibition was
demonstrated in the raw ethanolic extract by bioauto-
graphic techniques and broth microdilution assay for
sporulating fungi, by inhibition of hyphal growth for
filamentous fungi, and by paper disc and well plate
diffusion assays for yeasts. Otherwise, the comparison of
the antifungal potency of the extract with ketoconazole, a
well-known imidazole derivative, revealed that the extract
fungitoxic strength is lower than that of the standard drug
though ketoconazole is several times more cytotoxic than
the extract. It worth to take into account that despite the
clinical utility of antifungal azoles, several subjects require
investigations including the emergence of polyazole-resist-
ant isolates after long-term treatment with azoles (Hitch-
cook 1993; Johnson et al. 1995), and to decrease toxicity
and side-effects of the drug. Consequently, the search of
new plant sources linked with bioassays of the corres-
ponding crude extracts would contribute to the discovery
of new biologically active compounds. The extract frac-
tionation gave rise to the isolation of a fraction (Fr. B) with
fungitoxic activity and the different staining reagents
applied to TLC suggested the phenolic nature of this
fraction. The fluorescence under u.v. light and its maxi-
mum of absorption at 282 nm induced to think the
presence of a flavanone structure. Moreover, the staining of
the TLC with several reagents confirmed this result and
suggested the presence of two adjacent hydroxyl groups in
the B ring being one of them in position 4¢. Structural
analysis allowed to demonstrate that the isolated compound
is an O-glycoside with glucose and two pentoses in the
glycosidic fraction. Up to the present only one flavanone
aglycone, dihydromyricetin 3¢, 5¢-dimethyl ether (dihydro-
syringetin) was detected as component of the genus Larrea
during studies on the taxonomic relationships between
L. tridentate and L. divaricata (Sakakibara et al. 1976) but
its structure is different from the flavanone purified in our
study and its biological activity unknown.
Our data suggest that L. divaricata extract contains, at
least, one compound (a glycoside of a flavanone) with high
fungitoxic potency against yeasts and filamentous fungi.
This is the first step in a long process toward the
examination and structural elucidation of compounds with
antifungal ability in ethanolic extracts of L. divaricata Cav.
Moreover, this work underlines the importance of the
screening of biological activities of tropical ethno-medicinal
plants. Further testing in vivo and studies on the structure-
function relationships are now in progress.
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Piecková, E. and Roeijmans, H. (1999) Antibiotic secondary metabo-
lites of Dichotomyces cejpii. Mycopathologı́a 146, 121–126.
Quiroga, E.N., Sampietro, A.R. and Vattuone, M.A. (2001) Screening
of antifungal activities of selected medicinal plants. Journal of
Ethnopharmacology 74, 89–96.
Rauha, J.P., Remes, S., Heinonen, M., Hopia, A., Kahkonen, M., Kujala,
T., Pihlaja, K., Vuorela, H. et al. (2000) Antimicrobial effects of
Finnish plant extracts containing flavonoids and other phenolics
compounds. International Journal of Food Microbiology 56, 3–12.
Reyes Chilpa, R., Quiroz Vázquez, R.I., Jiménez Estrada, M., Navarro-
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